EME - 12/66/22

StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): A randomised, double-masked, sham- controlled, clinical trial comparing low-voltage X-ray irradiation with as needed ranibizumab, to as needed ranibizumab monotherapy

Project title: StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): A randomised, double-masked, sham- controlled, clinical trial comparing low-voltage X-ray irradiation with as needed ranibizumab, to as needed ranibizumab monotherapy

Call to action: 12/66 12/66 Retinal Disease

Research type: Primary Research

Chief investigator: Professor Timothy Jackson

Contractor: King's College London

Cost: £2,240,168.00

Co-investigators: Dr Patricia Clinch, Dr Yanzhong Wang, Professor Barnaby Reeves, Professor Janet Peacock, Professor Joe O'Sullivan, Professor Sarah Wordsworth, Professor Usha Chakravarthy.

Started: December 2014 | Status: Research in progress

ISRCTN: 12884465

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.